291 related articles for article (PubMed ID: 28819312)
1. Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles.
Pavlos R; McKinnon EJ; Ostrov DA; Peters B; Buus S; Koelle D; Chopra A; Schutte R; Rive C; Redwood A; Restrepo S; Bracey A; Kaever T; Myers P; Speers E; Malaker SA; Shabanowitz J; Jing Y; Gaudieri S; Hunt DF; Carrington M; Haas DW; Mallal S; Phillips EJ
Sci Rep; 2017 Aug; 7(1):8653. PubMed ID: 28819312
[TBL] [Abstract][Full Text] [Related]
2. HLA Class I restricted CD8+ and Class II restricted CD4+ T cells are implicated in the pathogenesis of nevirapine hypersensitivity.
Keane NM; Pavlos RK; McKinnon E; Lucas A; Rive C; Blyth CC; Dunn D; Lucas M; Mallal S; Phillips E
AIDS; 2014 Aug; 28(13):1891-901. PubMed ID: 24911354
[TBL] [Abstract][Full Text] [Related]
3. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships.
Hattotuwagama CK; Doytchinova IA; Flower DR
Methods Mol Biol; 2007; 409():227-45. PubMed ID: 18450004
[TBL] [Abstract][Full Text] [Related]
4. Amino acid signatures of HLA Class-I and II molecules are strongly associated with SLE susceptibility and autoantibody production in Eastern Asians.
Molineros JE; Looger LL; Kim K; Okada Y; Terao C; Sun C; Zhou XJ; Raj P; Kochi Y; Suzuki A; Akizuki S; Nakabo S; Bang SY; Lee HS; Kang YM; Suh CH; Chung WT; Park YB; Choe JY; Shim SC; Lee SS; Zuo X; Yamamoto K; Li QZ; Shen N; Porter LL; Harley JB; Chua KH; Zhang H; Wakeland EK; Tsao BP; Bae SC; Nath SK
PLoS Genet; 2019 Apr; 15(4):e1008092. PubMed ID: 31022184
[TBL] [Abstract][Full Text] [Related]
5. HLA-dependent hypersensitivity reaction to nevirapine in Chinese Han HIV-infected patients.
Gao S; Gui XE; Liang K; Liu Z; Hu J; Dong B
AIDS Res Hum Retroviruses; 2012 Jun; 28(6):540-3. PubMed ID: 21902584
[TBL] [Abstract][Full Text] [Related]
6. Nevirapine patch testing in Thai human immunodeficiency virus infected patients with nevirapine drug hypersensitivity.
Prasertvit P; Chareonyingwattana A; Wattanakrai P
Contact Dermatitis; 2017 Dec; 77(6):379-384. PubMed ID: 28782122
[TBL] [Abstract][Full Text] [Related]
7. HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients.
Chantarangsu S; Mushiroda T; Mahasirimongkol S; Kiertiburanakul S; Sungkanuparph S; Manosuthi W; Tantisiriwat W; Charoenyingwattana A; Sura T; Chantratita W; Nakamura Y
Pharmacogenet Genomics; 2009 Feb; 19(2):139-46. PubMed ID: 19104471
[TBL] [Abstract][Full Text] [Related]
8. Sequence variability analysis of human class I and class II MHC molecules: functional and structural correlates of amino acid polymorphisms.
Reche PA; Reinherz EL
J Mol Biol; 2003 Aug; 331(3):623-41. PubMed ID: 12899833
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the structure of naturally processed peptides bound by class I and class II major histocompatibility complex molecules.
Appella E; Padlan EA; Hunt DF
EXS; 1995; 73():105-19. PubMed ID: 7579970
[TBL] [Abstract][Full Text] [Related]
10. Human leukocyte antigen class-I variation is associated with atopic dermatitis: A case-control study.
Margolis DJ; Mitra N; Duke JL; Berna R; Margolis JD; Hoffstad O; Kim BS; Yan AC; Zaenglein AL; Chiesa Fuxench Z; Dinou A; Wasserman J; Tairis N; Mosbruger TL; Ferriola D; Damianos G; Kotsopoulou I; Monos DS
Hum Immunol; 2021 Aug; 82(8):593-599. PubMed ID: 33875297
[TBL] [Abstract][Full Text] [Related]
11. T cell-mediated hypersensitivity reactions to drugs.
Pavlos R; Mallal S; Ostrov D; Buus S; Metushi I; Peters B; Phillips E
Annu Rev Med; 2015; 66():439-54. PubMed ID: 25386935
[TBL] [Abstract][Full Text] [Related]
12. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
[TBL] [Abstract][Full Text] [Related]
13. Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium.
Chao MJ; Barnardo MC; Lui GZ; Lincoln MR; Ramagopalan SV; Herrera BM; Dyment DA; Sadovnick AD; Ebers GC
Hum Mol Genet; 2007 Aug; 16(16):1951-8. PubMed ID: 17584771
[TBL] [Abstract][Full Text] [Related]
14. Interaction of Nevirapine with the Peptide Binding Groove of HLA-DRB1*01:01 and Its Effect on the Conformation of HLA-Peptide Complex.
Hirasawa M; Hagihara K; Abe K; Ando O; Hirayama N
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29867033
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetic information derived from analysis of HLA alleles.
Gatanaga H; Honda H; Oka S
Pharmacogenomics; 2008 Feb; 9(2):207-14. PubMed ID: 18370849
[TBL] [Abstract][Full Text] [Related]
16. Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule.
Duyar H; Dengjel J; de Graaf KL; Wiesmüller KH; Stevanović S; Weissert R
Immunogenetics; 2005 Apr; 57(1-2):69-76. PubMed ID: 15711804
[TBL] [Abstract][Full Text] [Related]
17. Discontinuation of nevirapine because of hypersensitivity reactions in patients with prior treatment experience, compared with treatment-naive patients: the ATHENA cohort study.
Wit FW; Kesselring AM; Gras L; Richter C; van der Ende ME; Brinkman K; Lange JM; de Wolf F; Reiss P
Clin Infect Dis; 2008 Mar; 46(6):933-40. PubMed ID: 18271750
[TBL] [Abstract][Full Text] [Related]
18. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
Mortier MC; Jongert E; Mettens P; Ruelle JL
BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
[TBL] [Abstract][Full Text] [Related]
19. Deciphering complex patterns of class-I HLA-peptide cross-reactivity via hierarchical grouping.
Mukherjee S; Warwicker J; Chandra N
Immunol Cell Biol; 2015 Jul; 93(6):522-32. PubMed ID: 25708537
[TBL] [Abstract][Full Text] [Related]
20. Class II HLA-peptide binding prediction using structural principles.
Mohanapriya A; Lulu S; Kayathri R; Kangueane P
Hum Immunol; 2009 Mar; 70(3):159-69. PubMed ID: 19187794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
